Skip to content

Cosmos Health Inc.

COSM· NasdaqCore metricsCIK 1474167

Wholesale drugs, proprietaries & druggists’ sundries10 peers

Last sale
Nov 12, 2026 · -12.75%
Market cap
$20.80M
100.63M shares
Filings
640
$18.99M
Q2 2026+19.9% FY25 yoy
-$6.09M
Q2 2026N/M FY25 yoy
-$2.93M
Q2 2026N/M FY25 yoy
-$2.86M
Q2 2026derivedN/M FY25 yoy
-$0.10
Q2 2026N/M FY25 yoy
$1.80M
Q2 2026+127.1% FY25 yoy
$20.80M
—
0.3×
1.0×
-47.75%
—

Twelve months to Jun 30, 2026 · derived

Price

$0.206771.68%$0.5233past year
Nov 12, 2026 · IEX last sale
Figure
Range
IEX last saleClose of recordAs traded

Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.

Financials

Revenue

$65.27MFY 2025
$65.27M0FY 2014FY 2019FY 2025
PeriodEndedValueKindSource trail
FY 20252025-12-31$65,271,815reported
FY 20242024-12-31$54,426,402reported
FY 20232023-12-31$53,376,874reported
FY 20222022-12-31$50,347,652reported
FY 20212021-12-31$56,239,667reported
FY 20202020-12-31$55,406,337reported
FY 20192019-12-31$39,676,385reported
FY 20182018-12-31$37,083,882reported
FY 20172017-12-31$30,013,379 revisedreported
FY 20162016-12-31$6,755,436reported
FY 20152015-12-31$533,802reported
FY 20142014-12-31$7,639,022reported

Capital returns

Dividends and buybacks · FY2020 to FY2024
Fiscal yearDividendsBuybacksTotalPer shareSharesShares · yoyof free cash flow
FY2024—$0.00$0.00—27.28M sh+55.0%—
FY2023—$100.45K$100.45K—17.61M sh+65.8%—
FY2021—$376.86K$376.86K—17.54M sh+9.2%—
FY2020—$200.00K$200.00K—16.07M sh+20.8%—

Segments

Segments
Revenue by Segments, FY2023 to FY2025FY2023Wholesale · FY2023 · $50.74MNutraceuticals and Pharmaceuticals · FY2023 · $2.29MPharma manufacturing · FY2023 · $344.71KFY2024Wholesale · FY2024 · $51.59MNutraceuticals and Pharmaceuticals · FY2024 · $1.97MPharma manufacturing · FY2024 · $865.37KFY2025Wholesale · FY2025 · $59.32MNutraceuticals and Pharmaceuticals · FY2025 · $4.26MPharma manufacturing · FY2025 · $1.69MOther · FY2025 · $1.23K
LineFY2025ShareChange
Wholesale$59.32M91%+15.0%
Nutraceuticals and Pharmaceuticals$4.26M6.5%+116.7%
Pharma manufacturing$1.69M2.6%+95.2%
Other$1.23K0.0%—
Total$65.27M

From the 10-K filed Apr 15, 2026COSM

Wholesale drugs, proprietaries & druggists’ sundries

Cosmos Health Inc. is the 6th largest of the 11 covered companies the SEC files under this code, by revenue. SIC 5122

Peers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in revenue first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.

Cosmos Health Inc. · CIK 1474167 · Engraved from SEC EDGAR